about
Experimental design and primary data analysis methods for comparing adaptive interventions.Comparison of randomization techniques for clinical trials with data from the HOMERUS-trial.Statistical considerations in the design, analysis, and interpretation of comparative clinical studies.Dynamic randomization and a randomization model for clinical trials dataCurrent issues in the design and interpretation of clinical trials.Patient subsets and variation in therapeutic efficacy.Randomization in substance abuse clinical trials.Randomization in cancer clinical trials: permutation test and development of a computer program.Basic design considerations for clinical trials in oncology.Use of randomisation in clinical trials: a survey of UK practice.Partnering with health system operations leadership to develop a controlled implementation trial.An evaluation of constrained randomization for the design and analysis of group-randomized trialsStatistical issues in the use of dynamic allocation methods for balancing baseline covariates.Randomization in clinical trials: stratification or minimization? The HERMES free simulation software.The benefit of stratification in clinical trials revisited.Weighted re-randomization tests for minimization with unbalanced allocation.Matching on-the-fly: sequential allocation with higher power and efficiency.Pharmacokinetics of metronidazole in foals: influence of age within the neonatal period.Optimum biased-coin designs for sequential treatment allocation with covariate information by A. C. Atkinson, Statistics in Medicine 1999; 18:1741-1752.A simulation study of the validity and efficiency of design-adaptive allocation to two groups in the regression situation.
P2860
Q30571530-A6D0AA79-B39E-464B-98C6-6C0549DDC637Q31014531-AA90875A-038D-4FB5-9116-2BB01097DC63Q33615561-06D20C8C-B2E2-49C8-A75C-0485EAA76964Q34327162-D772B8A2-0EE5-494C-890A-0CDC2F621987Q34483874-BB3D4320-A919-4D8B-B06A-654C52F4850CQ34511725-C7F3D14D-1BBD-4DA2-8A03-964FA016A789Q34538521-FB0F543A-E707-4DB0-A458-4B5145E071E0Q35033554-3588E75D-253A-40C0-952E-3AF03D19304DQ36381909-D5EDD072-6258-47EA-BF91-1B2E57A62004Q36465972-A488D82C-472A-4ED8-8BAD-0D0F3F901079Q36611809-A054F5A9-B0DC-469E-8944-7476E3911E6BQ36784579-F3C61622-B42B-4B54-8075-D4FFA93B3FAEQ38253744-0A4288FA-ABC2-4C09-8FC5-6490CD7C8EA8Q39458412-ADEF4AA8-9F50-4293-9787-67802A763B18Q44454316-3BDB28DE-B640-445F-B700-C620B736758FQ44991158-832707CB-3B8C-4A56-9C84-A6A0D7F7F914Q45885236-70617D18-B7D7-4EA3-8265-195D518897F2Q45941244-EB1B685C-DE59-488B-86F9-A79E49985281Q52929220-DE1C8AB7-2627-40EF-98EE-03BBFA9A4DECQ53065480-FBEA9B91-44A5-4FE5-92B7-F0BF312C11FE
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Restricted randomization designs in clinical trials.
@en
Restricted randomization designs in clinical trials.
@nl
type
label
Restricted randomization designs in clinical trials.
@en
Restricted randomization designs in clinical trials.
@nl
prefLabel
Restricted randomization designs in clinical trials.
@en
Restricted randomization designs in clinical trials.
@nl
P356
P1433
P1476
Restricted randomization designs in clinical trials.
@en
P2093
P304
P356
10.2307/2530354
P407
P577
1979-06-01T00:00:00Z